FindTrial
Sign In

Safety and feasibility of laparoscopic liver resection for hepatocellular carcinoma with clinically significant portal hypertension: a retrospective multicenter study

Safety and feasibility of laparoscopic liver resection for hepatocellular carcinoma with clinically significant portal hypertension: a retrospective multicenter study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200059484
Enrollment
Unknown
Registered
2022-05-02
Start date
2022-04-30
Completion date
Unknown
Last updated
2024-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular carcinoma

Interventions

Group 1:
Group 2:

Sponsors

Run Run Shaw Hospital, Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with portal hypertension who received minimally invasive hepatectomy in each center within a continuous period of time and patients with non-portal hypertension who underwent minimally invasive hepatectomy within the corresponding period; 2. Postoperative pathological diagnosis of hepatocellular carcinoma; 3. Minimally invasive liver resection includes hand-assisted laparoscopy, robotic laparoscopy and simple laparoscopic surgery; 4. The surgery date is before November 31, 2021.

Exclusion criteria

Exclusion criteria: 1. The patient has a history of other malignant tumors; 2. Patients with incomplete clinical data.

Design outcomes

Primary

MeasureTime frame
Postoperative complications;—

Secondary

MeasureTime frame
Postoperative hospital stay;Operation time;Blood loss;Incidence of postoperative liver failure;—

Countries

China

Contacts

Public ContactXiao Liang

Run Run Shaw Hospital, Zhejiang University School of Medicine

srrshlx@zju.edu.cn+86 13588708506

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026